CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- CT ORDER Other Confidential Order
- UPLOAD Other SEC-generated Letter
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- PRER14A Other PRER14A
- PRE 14A Proxy Proxy Statement (Preliminary)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Other events
- 424B5 Offering Prospectus
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale SVP, Chief Operating Officer sold 6,972 shares at $8.70 ($60,656)
- 4 Open-market sale SVP, Chief Legal Officer sold 7,050 shares at $8.70 ($61,335)
Page 22 of 45 · 886 filings